Skip to main content
Premium Trial:

Request an Annual Quote

Brian Bullard, Thomas Colatsky, Michael Liebman, Eldred Ribeiro, Charles Guo, Wolfgang Rumpf, Lorie Karnath

Premium

Paradigm Genetics has hired Brian Bullard as senior director of computational systems biology. Bullard has held senior-level informatics positions at Morphochem, AxCell Biosciences, PE Informatics, Gene Logic, and Science and Technology Corporation. He will report to Thomas Colatsky, VP of healthcare research. Paradigm also appointed Michael Liebman, director of biomedical informatics at the Abramson Family Cancer Research Institute at the University of Pennsylvania School of Medicine, to its scientific advisory board.

 

Rescentris, a company formed by three LabBook executives, has hired several new LabBook alums. Eldred Ribeiro, Charles Guo, and Wolfgang Rumpf have joined as directors of software development, biomedical informatics, and product development, respectively. Lorie Karnath has been appointed as managing director and chairperson of the company’s scientific advisory board.

 

Filed under

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.